News Archive

Archives: Search / 2019 / 2018 / 2017 / 2016 / 2015 / 2014 / 2013 / 2012

2017 Archives

Dec 20, 2017
Dec 15, 2017
- Intranasal abuse-deterrent claim to be added to ARYMO ER prescribing information label -
Nov 28, 2017
Nov 20, 2017
Nov 16, 2017
Nov 8, 2017
-- Company to host conference call today at 8:30 a.m. ET --
Nov 6, 2017
Oct 30, 2017
Oct 25, 2017
Sep 18, 2017
Sep 8, 2017
--Additional Study Examined Reasons Why Opioid Abusers Progress to More Dangerous Routes of Administration Beyond Oral Abuse--
Sep 6, 2017
Sep 5, 2017
--Ascend Therapeutics women's health specialty sales representatives call on 9,000 women's healthcare practitioners --
Aug 29, 2017
--Five posters to be presented including three highlighting abuse-deterrent profile of ARYMO® ER--
Aug 9, 2017
--Revenue increased 81% year over year and 15% over first quarter--
Jul 26, 2017
Jul 11, 2017
Jul 6, 2017
Jul 5, 2017
Jun 20, 2017
Jun 7, 2017
-- 37 Ascend Therapeutics women's health specialty sales representatives to call on 9,000 women's healthcare practitioners --
Jun 6, 2017
Jun 5, 2017
-- Patent covers combination products with precise drug delivery properties --
May 18, 2017
-Results suggest that replacement of non-abuse-deterrent, extended-release morphine with ARYMO ER could lead to potential reductions in opioid abuse-related events-
May 17, 2017
- Data show ARYMO ER does not exhibit alcohol dose dumping and can be taken with or without food -
 

 

 

CAREERS

Find out more about opportunities with Zyla Life Sciences.

Career Contact
careers@zyla.com

QUICK LINKS

Sign up for Zyla Life Sciences email alerts.

Investor Contact
ir@zyla.com
Media Contact
media@zyla.com

ZYLA LIFE SCIENCES

U.S. Operations
600 Lee Road, Suite 100
Wayne, PA 19087
Tel: 610.833.4200

© Copyright 2019 Zyla Life Sciences
All rights reserved.